Article Versions Notes

Fresnais M, Roth A, Foerster KI, Jäger D, Pfister SM, Haefeli WE, Burhenne J, Longuespée R. Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay. Cancers. 2020; 12(7):1897. https://doi.org/10.3390/cancers12071897

Fresnais, Margaux, André Roth, Kathrin I. Foerster, Dirk Jäger, Stefan M. Pfister, Walter E. Haefeli, Jürgen Burhenne, and Rémi Longuespée. 2020. "Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay" Cancers 12, no. 7: 1897. https://doi.org/10.3390/cancers12071897

Fresnais, M., Roth, A., Foerster, K. I., Jäger, D., Pfister, S. M., Haefeli, W. E., Burhenne, J., & Longuespée, R. (2020). Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay. Cancers, 12(7), 1897. https://doi.org/10.3390/cancers12071897